VIS Introduction

Watch our animated introduction to VIS and Optimal Keratoplasty (Opti-K™) online, highlighting our technology, solutions, and recent milestones regarding FDA clinical trials for the treatment of Presbyopia and Health Canada studies for the treatment of Age-Related Macular Degeneration (AMD).

Listen to our Key Opinion Leader, Marguerite B. McDonald, MD, FACS, discuss Presbyopia and Optimal Keratoplasty (Opti-K™) at the ASCRS Conference Steinert Lecture, “Presbyopia the Next Horizon”.

Read our January 2024 Cover Story at Cataract and Refractive Surgery Today, “A New Approach to Thermal Keratoplasty”.

Learn more about VIS and Opti-K™ by contacting us today. If you are an accredited investor and would like to learn more about our upcoming Private Placement Memorandum (PPM), please contact us directly:

VIS understands that sight is very precious; the one sense people fear losing most. VIS’ mission is to commercialize and scale proprietary, laser-based optical device systems for ophthalmologists to treat patients using, safe, fast, and affordable procedures with excellent results.

DISCLAIMER: The VIS Optimal Keratoplasty (Opti-K™) System is an investigational device, and it is not available for sale or use in the United States.

VIS LLC
2800 Dallas Parkway, Suite 100
Plano, TX 75093
United States of America
Monday - Friday 9:00 AM - 5:00 PM
[email protected]